🇺🇸 FDA
Patent

US 9474730

Methods and compositions for use with K-ras mediated disorders

granted A61KA61K31/137A61K45/06

Quick answer

US patent 9474730 (Methods and compositions for use with K-ras mediated disorders) held by The Board of Regents of the University of Texas System expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/137, A61K45/06